Table 3.
Study | Findings | n/N (%) |
---|---|---|
Toubiana et al. [2] | Rash | 16/21 (76) |
Bilateral bulbar conjunctival injection | 17/21 (81) | |
Lips and oral cavity changes | 16/21 (76) | |
Whittaker et al. [3] | Erythematous rash | 30/58 (52) |
Conjunctivitis | 26/58 (45) | |
Mucus membrane changes and red cracked lips | 17/58 (29) | |
Swollen hands and feet | 9/58 (16) | |
Cabrero-Hernandez et al. [8] | Maculopapular rash in genital | 1/5 (20) |
Maculopapular rash in trunk and extremities | 1/5 (20) | |
Riphagen et al. [10] | Conjunctivitis | 5/8 (63) |
Rash | 4/8 (50) | |
Kaushik et al. [11] | Mucocutaneous involvement | 7/33 (21) |
Conjunctivitis | 12/33 (36) | |
Rash | 14/33 (42) | |
Davies et al. [12] | Conjunctivitis | 23/78 (29) |
Rash | 35/78 (45) | |
Ng et al. [14] | Conjunctivitis | 3/3 (100) |
Maculopapular rash | 1/3 (33) | |
Urticarial rash | 1/3 (33) | |
Cracked lips | 1/3 (33) | |
Pouletty et al. [17] | Skin rash | 13/16 (81) |
Hands/feet erythema | 11/16 (68) | |
Conjunctivitis | 15/16 (94) | |
Dry cracked lips | 14/16 (87) | |
Grimaud et al. [18] | Skin rash | 10/20 (50) |
Conjunctivitis | 6/20 (30) | |
Cheilitis | 5/20 (25) | |
Cheung et al. [20] | Rash | 12/17 (71) |
Conjunctivitis | 11/17 (65) | |
Lip redness/swelling | 9/17 (53) |